CALL FOR ABSTRACTS
The APASL 2026 STC Singapore Organising Committee warmly invites researchers to submit their abstracts for an opportunity to showcase their work. All submissions will undergo reviews by the Abstract Selection Committee, who will then determine the final mode of presentation.
Submit Abstract →How to submit abstracts
1 Apr 2026
1 May 2026
15 May 2026
Abstract Themes & Categories
Elimination Forum
- Dynamic Change in Epidemiology and Disease Burden in Elimination Era
- The Role of Government Aid and/or Society in Elimination
- Advocacy Stigma and Public Education Campaigns
- Micro-Elimination Strategy and Technique
- Simplified Service including Decentralization, Integrated Delivery System and Task Sharing in Elimination
- Service Delivery to Reach the Community
- Community Engagement in Elimination
- Gender Equality in Elimination
- Drug Accessibility and Cost Effectiveness
Public Health
- Epidemiology & Natural History
- Vaccination, Prevention and Control Policy
- Cost-Effectiveness and Accessibility
Basic Science & Pathology
- Liver Immunology and Virology
- Cellular and Molecular Biology
- Gut Liver Brain Axis and Microbiome
- Animal Models
Hepatitis B and Delta
- Basic Science and Translational Research
- Clinical Aspects
- Research and Trials: Novel Targets and Strategies
Hepatitis C
- Basic Science and Translational Research
- Clinical Aspects
- Screening and Elimination Strategy
Others Hepatitis, Infections and the Liver
- Hepatitis E and Others Hepatitis
- HIV and the Liver
- COVID-19 and the Liver
- Other Infections and the Liver
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Toxicity
- Basic Science and Translational Research
- Clinical Aspects
- Research and Trials: Novel Targets and Strategies
Liver Injury and Toxicity
- Drug-Induced Liver Injury (DILI)
- Hepatotoxicity
- Alcohol-related Liver Disease
Pediatric and Genetics
- Basic Science and Translational Research
- Clinical Aspects
- Rare Liver Disease
Liver Fibrogenesis and Cirrhosis
- Basic Research: Experimental and Pathophysiology
- Diagnosis and Staging
- Herbal and Traditional Medicine
- Research and Trials: Novel Targets and Strategies
Management of Advanced Chronic Liver Disease (ACLD)
- Portal Hypertension and Other Complications
- Vascular Disorder
- Acute on Chronic Liver Failure (ACLF) and Critical Care
- Palliative Care: Nutrition and Nursing
Liver Oncology
- Basic and Translational Research
- Diagnosis and Liver Imaging
- Molecular Pathogenesis and Biomarkers
- Metastatic Liver Tumors, Cholangiocarcinomas (CCC) & Others
Liver Cancer Management
- Surgical Treatment and Ablation
- Radiotherapy, Chemotherapy, Interventions and Combination Therapy
- Targeted Drug and Immunotherapy
- Research and Trials: Novel Targets and Strategies
Liver Surgery and Transplantation
- Basic Science
- Hepato-Pancreato-Biliary (HPB) Surgery
- Liver Transplantation
- Rehabilitation and Nursing
New Technology
- Artificial Intelligence and Data Analysis
- Imaging and 3D Printing
- Robotic Surgery
- Biomarkers and Drug Targets Discovery
IBD
NUTRITION / MICROBIOME
PANCREATIBILIARY
ENDOSCOPY
OTHERS
Abstract Structure
1. Title: The title should indicate the abstract content. Company or trade names, special symbols, characters, and uncommon abbreviations are not permitted.
2. Type: You may select one of the following types of abstract: Poster Presentation or Oral Presentation
3. Content: Abstract body should not exceed 250 words. Content must be organized in the following structure: "Objectives", "Materials and Methods", "Results", and "Conclusion".
4. Supporting Image/Graph/Illustration (Optional): You may submit a supporting image, graph, or illustration for your abstract.
Terms & Conditions
- All abstracts must be submitted in English.
- Only online submissions are accepted.
- Abstracts should contain original material not published or presented internationally.
- Presenting authors must register for the congress.
- Ensure all co-authors are listed prior to submission. No additions will be allowed afterward.